<DOC>
	<DOCNO>NCT00000331</DOCNO>
	<brief_summary>The purpose study assess abuse liability examine reinforce effect intravenous buprenorphine buprenorphine/naloxone combination healthy , non-drug dependent volunteer .</brief_summary>
	<brief_title>Buprenorphine/Naloxone Treatment Opioid Dependence-Experiment II-3 - 6</brief_title>
	<detailed_description>available time</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<criteria>Individuals must healthy , nondrug dependent volunteer , least 18 year age , prior history drug alcohol abuse dependence . Subjects must minimal experience opioids ( e.g . least two prior exposure ) Individuals evidence active Diagnostic Statistical Manual Mental Disorders ( DSMIV ) Axis I psychiatric disorder ( e.g . psychosis , manicdepressive illness , organic psychiatric disorder ) , significant medical illness ( e.g. , liver cardiovascular disease ) pregnant female subject exclude study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Heroin Dependence</keyword>
</DOC>